STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$99,792
-83.5%
23,100
-74.8%
0.00%
-100.0%
Q2 2023$605,002
+59.1%
91,806
+63.9%
0.00%0.0%
Q1 2023$380,254
-67.2%
56,002
-64.3%
0.00%
-66.7%
Q4 2022$1,158,656
-32.3%
156,787
-9.5%
0.00%
-25.0%
Q3 2022$1,712,000
-24.8%
173,288
-17.1%
0.00%
-33.3%
Q2 2022$2,277,000
+20.3%
208,927
+24.9%
0.01%
+50.0%
Q1 2022$1,893,000
-27.9%
167,3420.0%0.00%
-20.0%
Q4 2021$2,626,000
-3.6%
167,342
+5.3%
0.01%0.0%
Q3 2021$2,723,000
-13.3%
158,869
+8.8%
0.01%
-16.7%
Q2 2021$3,141,000
+33.7%
146,009
-6.7%
0.01%
+20.0%
Q1 2021$2,350,000
+417.6%
156,475
+353.2%
0.01%
+400.0%
Q4 2020$454,000
+35.9%
34,5240.0%0.00%0.0%
Q3 2020$334,000
-15.4%
34,5240.0%0.00%0.0%
Q2 2020$395,000
+10.3%
34,5240.0%0.00%0.0%
Q1 2020$358,000
-36.9%
34,5240.0%0.00%0.0%
Q4 2019$567,000
+23.3%
34,524
-0.4%
0.00%0.0%
Q3 2019$460,000
-5.7%
34,6540.0%0.00%0.0%
Q2 2019$488,000
-23.1%
34,654
+0.4%
0.00%
-50.0%
Q1 2019$635,000
-29.9%
34,514
-0.5%
0.00%
-33.3%
Q4 2018$906,000
+13.8%
34,6740.0%0.00%
+50.0%
Q3 2018$796,000
+20.4%
34,6740.0%0.00%0.0%
Q2 2018$661,000
+15.4%
34,674
+1.9%
0.00%0.0%
Q1 2018$573,000
+10.8%
34,0240.0%0.00%
+100.0%
Q4 2017$517,000
-15.1%
34,0240.0%0.00%
-50.0%
Q3 2017$609,000
+9.7%
34,0240.0%0.00%0.0%
Q2 2017$555,000
-63.2%
34,024
-68.4%
0.00%
-50.0%
Q1 2017$1,509,000
-12.2%
107,7680.0%0.00%
-20.0%
Q4 2016$1,719,000
-11.3%
107,768
-7.5%
0.01%
-16.7%
Q3 2016$1,939,000
+93.3%
116,503
+30.0%
0.01%
+100.0%
Q2 2016$1,003,000
+35.0%
89,624
+0.9%
0.00%0.0%
Q1 2016$743,000
-10.2%
88,8440.0%0.00%0.0%
Q4 2015$827,000
-41.6%
88,844
-29.2%
0.00%
-40.0%
Q3 2015$1,416,000
-17.3%
125,498
-7.1%
0.01%
-16.7%
Q2 2015$1,713,000
+375.8%
135,022
+249.0%
0.01%
+500.0%
Q1 2015$360,000
-38.9%
38,684
-6.0%
0.00%
-50.0%
Q4 2014$589,000
+37.0%
41,134
-0.7%
0.00%
+100.0%
Q3 2014$430,000
-35.8%
41,4360.0%0.00%
-50.0%
Q2 2014$670,000
-0.1%
41,436
+0.4%
0.00%0.0%
Q1 2014$671,000
+29.0%
41,278
-1.5%
0.00%0.0%
Q4 2013$520,000
+13.0%
41,8880.0%0.00%
+100.0%
Q3 2013$460,000
+36.1%
41,8880.0%0.00%0.0%
Q2 2013$338,00041,8880.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders